Putting the Patient First in IBD Care: Risk Assessment and Treatment

Program Overview

The goal of this activity is to provide education about tools for assessing the risk of disease complications in patients with IBD and how to personalize treatment based on patient goals and individual disease considerations.

Credit Expired

Target Audience

This activity is intended for gastroenterology and primary care physicians, nurse practitioners, and physician assistants who manage patients with inflammatory bowel disease (IBD).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Discuss the importance of and methods by which to perform early risk stratification for patients with IBD
  • Apply evidence-based IBD management strategies based on risk of disease complications
  • Implement individualized IBD treatment approaches based on expected benefits and risks

Activity Faculty

Corey Siegel MD

Corey A. Siegel, MD, MS

Professor of Medicine and of The Dartmouth Institute for Health Policy and Clinical Practice
Geisel School of Medicine at Dartmouth
Section Chief, Gastroenterology and Hepatology
Co-Director, IBD Center
Dartmouth-Hitchcock Medical Center
Lebanon, NH


Marla C. Dubinsky, MD

Professor, Pediatrics and Medicine
Chief, Pediatric Gastroenterology and Nutrition
Co-Director, Susan and Leonard Feinstein IBD Clinical Center
Icahn School of Medicine
Kravis Children’s Hospital Mount Sinai
New York, NY


Iris Dotan, MD

Director, Division of Gastroenterology
Rabin Medical Center
Petah Tikva, Israel
Sackler Faculty of Medicine
Tel Aviv University
Tel Aviv, Israel

Jessica Caron, MHCDS

Patient Advocate
Goffstown, NH


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources